0.707
price down icon5.73%   -0.043
after-market アフターアワーズ: .71 0.003 +0.42%
loading
前日終値:
$0.75
開ける:
$0.757
24時間の取引高:
616.85K
Relative Volume:
0.61
時価総額:
$112.21M
収益:
-
当期純損益:
$-41.23M
株価収益率:
-1.01
EPS:
-0.7
ネットキャッシュフロー:
$-11.54M
1週間 パフォーマンス:
-10.78%
1か月 パフォーマンス:
-57.41%
6か月 パフォーマンス:
-50.90%
1年 パフォーマンス:
-84.56%
1日の値動き範囲:
Value
$0.70
$0.7767
1週間の範囲:
Value
$0.70
$0.935
52週間の値動き範囲:
Value
$0.395
$5.25

Renovaro Inc Stock (RENB) Company Profile

Name
名前
Renovaro Inc
Name
セクター
Healthcare (1174)
Name
電話
45 39179840
Name
住所
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Name
職員
25
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
RENB's Discussions on Twitter

RENB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RENB
Renovaro Inc
0.707 112.21M 0 -41.23M -11.54M -0.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.00 108.68B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
681.58 74.90B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
640.52 38.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
246.27 31.76B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
111.93 26.83B 3.30B -501.07M 1.03B -2.1146

Renovaro Inc (RENB) 最新ニュース

pulisher
Jan 19, 2025

Short Interest in Renovaro Inc. (NASDAQ:RENB) Rises By 30.7% - MarketBeat

Jan 19, 2025
pulisher
Jan 13, 2025

Renovaro Inc. appoints new CFO Nathen Fuentes By Investing.com - Investing.com South Africa

Jan 13, 2025
pulisher
Jan 13, 2025

Renovaro Inc. appoints new CFO Nathen Fuentes - Investing.com

Jan 13, 2025
pulisher
Jan 11, 2025

Geode Capital Management LLC Decreases Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World

Jan 11, 2025
pulisher
Jan 11, 2025

Barclays PLC Has $34,000 Stock Position in Renovaro Inc. (NASDAQ:RENB) - Defense World

Jan 11, 2025
pulisher
Jan 09, 2025

Renovaro To Buy Predictive Oncology in All-Stock Deal - Pulse 2.0

Jan 09, 2025
pulisher
Jan 09, 2025

Renovaro Biosciences Subsidiary Appoints New CEO - MSN

Jan 09, 2025
pulisher
Jan 08, 2025

Renovaro appoints Nathen Fuentes as finance chief - MSN

Jan 08, 2025
pulisher
Jan 08, 2025

Renovaro Biosciences Merges with Predictive Oncology - MSN

Jan 08, 2025
pulisher
Jan 08, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Predictive Oncology Inc.POAI - The Malaysian Reserve

Jan 08, 2025
pulisher
Jan 07, 2025

PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc.POAI - Marketscreener.com

Jan 07, 2025
pulisher
Jan 07, 2025

Renovaro Inc. appoints new CEO for subsidiary By Investing.com - Investing.com Australia

Jan 07, 2025
pulisher
Jan 07, 2025

Nathen Fuentes Joins Renovaro as Chief Financial Officer - citybiz

Jan 07, 2025
pulisher
Jan 07, 2025

Renovaro BioSciences issues shareholder letter, provides corporate update - TipRanks

Jan 07, 2025
pulisher
Jan 07, 2025

Renovaro Taps Nathen Fuentes as Finance Chief - MarketWatch

Jan 07, 2025
pulisher
Jan 07, 2025

Renovaro Issues Shareholder Letter and Provides Corporate Update - The Manila Times

Jan 07, 2025
pulisher
Jan 07, 2025

Renovaro Inc. appoints new CEO for subsidiary - Investing.com

Jan 07, 2025
pulisher
Jan 06, 2025

Renovaro To Buy Predictive Oncology In All-Stock Deal - Pulse 2.0

Jan 06, 2025
pulisher
Jan 06, 2025

Predictive Oncology shares rise 71% as takeover by Renovaro is announced - Mugglehead

Jan 06, 2025
pulisher
Jan 06, 2025

Renovaro to Acquire Predictive Oncology - citybiz

Jan 06, 2025
pulisher
Jan 06, 2025

M&A: Predictive Oncology to be Acquired by Renovaro - HIT Consultant

Jan 06, 2025
pulisher
Jan 06, 2025

POAI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Predictive Oncology Inc. Is Fair to Shareholders - Business Wire

Jan 06, 2025
pulisher
Jan 06, 2025

Renovaro to acquire Predictive Oncology in all-stock transaction - TipRanks

Jan 06, 2025
pulisher
Jan 06, 2025

Renovaro to Acquire Predictive Oncology in All-Stock Transaction - The Manila Times

Jan 06, 2025
pulisher
Jan 06, 2025

Predictive Oncology in Deal to Be Sold to Renovaro - MarketWatch

Jan 06, 2025
pulisher
Jan 06, 2025

Renovaro to Acquire Predictive Oncology in All-Stock Transaction - Benzinga

Jan 06, 2025
pulisher
Jan 06, 2025

Predictive Oncology Announces Agreement to be Acquired by Renovaro - GlobeNewswire

Jan 06, 2025
pulisher
Jan 06, 2025

Predictive Oncology to Be Acquired by Renovaro in AI-Driven Cancer Research Merger - StockTitan

Jan 06, 2025
pulisher
Jan 05, 2025

Renovaro Inc. entered into a binding letter of intent to acquire Predictive Oncology Inc. for for $6.2 million. - Marketscreener.com

Jan 05, 2025
pulisher
Jan 04, 2025

State Street Corp Acquires 48,114 Shares of Renovaro Inc. (NASDAQ:RENB) - Defense World

Jan 04, 2025
pulisher
Dec 31, 2024

Short Interest in Renovaro Inc. (NASDAQ:RENB) Expands By 27.7% - MarketBeat

Dec 31, 2024
pulisher
Dec 30, 2024

Renovaro appoints new CEO for AI-driven diagnostics arm By Investing.com - Investing.com South Africa

Dec 30, 2024
pulisher
Dec 30, 2024

Renovaro Inc. Appoints Maurice van Tilburg as CEO of RenovaroCube Amid Strategic Growth in AI-Powered Cancer Diagnostics - Tandav Media

Dec 30, 2024
pulisher
Dec 30, 2024

Renovaro appoints new CEO for AI-driven diagnostics arm - Investing.com India

Dec 30, 2024
pulisher
Dec 30, 2024

Renovaro Inc. Appoints Maurice van Tilburg as CEO of RenovaroCube to Advance AI-Powered Cancer Diagnostics - Tandav Media

Dec 30, 2024
pulisher
Dec 30, 2024

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV - The Manila Times

Dec 30, 2024
pulisher
Dec 24, 2024

RENB Stock Price and Chart — NASDAQ:RENB - TradingView

Dec 24, 2024
pulisher
Dec 23, 2024

Renovaro Inc. Receives Grant Approval for LUMINA Project, an AI-Powered Minimal Residual Disease Detection Platform for Lung Cancer - Nasdaq

Dec 23, 2024
pulisher
Dec 23, 2024

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program - GlobeNewswire

Dec 23, 2024
pulisher
Dec 20, 2024

Renovaro regains Nasdaq compliance with bid price rule - Investing.com India

Dec 20, 2024
pulisher
Dec 20, 2024

Renovaro Regains Compliance with NASDAQ Listing Requirement - The Manila Times

Dec 20, 2024
pulisher
Dec 20, 2024

Strategic Collaboration with Nebul to Employ NVIDIA Cutting - openPR

Dec 20, 2024
pulisher
Dec 20, 2024

Renovaro teams up with Nebul for AI-driven cancer detection - Investing.com

Dec 20, 2024
pulisher
Dec 20, 2024

Renovaro Inc. Partners with Nebul to Launch GEDi CUBE Next Generation AI Healthcare Cloud Solutions - Nasdaq

Dec 20, 2024
pulisher
Dec 20, 2024

Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection - GlobeNewswire

Dec 20, 2024
pulisher
Dec 14, 2024

Renovaro (NASDAQ:RENB) Stock Price Up 2.3%Here's What Happened - MarketBeat

Dec 14, 2024
pulisher
Nov 21, 2024

Renovaro (NASDAQ:RENB) Trading Up 6.5%What's Next? - MarketBeat

Nov 21, 2024
pulisher
Nov 16, 2024

Renovaro: Fiscal Q1 Earnings Snapshot - New Haven Register

Nov 16, 2024

Renovaro Inc (RENB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Renovaro Inc (RENB) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
William Anderson Wittekind
10% Owner
Jul 17 '24
Sale
1.46
16,362
23,889
841,433
William Anderson Wittekind
10% Owner
Jul 15 '24
Sale
1.41
21,954
30,955
875,795
William Anderson Wittekind
10% Owner
Jul 10 '24
Sale
1.51
75,000
113,250
894,645
William Anderson Wittekind
10% Owner
Jul 11 '24
Sale
1.51
14,896
22,493
897,749
William Anderson Wittekind
10% Owner
Jul 09 '24
Sale
1.53
4,630
7,084
969,645
William Anderson Wittekind
10% Owner
Jul 05 '24
Sale
1.55
60,000
93,000
974,275
William Anderson Wittekind
10% Owner
Jul 03 '24
Sale
1.51
50,000
75,500
1,034,275
William Anderson Wittekind
10% Owner
Jul 01 '24
Sale
1.56
60,000
93,600
1,118,828
William Anderson Wittekind
10% Owner
Jul 02 '24
Sale
1.54
34,553
53,212
1,084,275
William Anderson Wittekind
10% Owner
Jun 26 '24
Sale
1.57
50,000
78,500
1,193,499
$30.75
price down icon 0.65%
$71.93
price down icon 0.75%
$19.03
price up icon 4.62%
$358.93
price down icon 2.04%
biotechnology ONC
$210.08
price up icon 2.31%
$111.93
price down icon 0.74%
大文字化:     |  ボリューム (24 時間):